Synapse - Works

Results (4760)

Impact of vision loss among survivors of childhood central nervous system astroglial tumors

Journal Article

De Blank, P. M. K.; Fisher, M. J.; Lu, L.; Leisenring, W. M.; Ness, K. K.; Sklar, C. A.; Stovall, M.; Vukadinovich, C.; Robison, L. L.; Armstrong, G. T.; more...
Cancer (2016)

Fulltext@MSK | Save

Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study

Journal Article

Friedman, D. N.; Chou, J. F.; Oeffinger, K. C.; Kleinerman, R. A.; Ford, J. S.; Sklar, C. A.; Li, Y.; McCabe, M. S.; Robison, L. L.; Marr, B. P.; more...
Cancer (2016)

Fulltext@MSK | Save

Activation of the cytosolic RNA receptor RIG-I in tumor and immune cells triggers efficient anti-tumor immunity and synergizes with checkpoint blockade

Meeting Abstract

Heidegger, S.; Wintges, A.; Kreppel, D.; Bscheider, M.; Bek, S.; Fischer, J.; Schmickl, M.; Ruland, J.; van den Brink, M.; Peschel, C.; more...
Oncology Research and Treatment (2016)

Fulltext@MSK | Save

A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (Dox) with or without olaratumab (IMC-3G3), a human anti-platelet-derived growth factor a (pdgfra) monoclonal antibody, in advanced soft tissue sarcoma (sts)

Meeting Abstract

Tap, W.; Jones, R. L.; Chmelowski, B.; Elias, A. A.; Adkins, D.; Van Tine, B. A.; Agulnik, M.; Cooney, M.; Livingston, M. B.; Pennock, G.; more...
Oncology Research and Treatment (2016)

Fulltext@MSK | Save

Embolotherapy for neuroendocrine tumor liver metastases: Prognostic factors for hepatic progression-free survival and overall survival

Meeting Abstract

Chen, J. X.; Rose, S.; White, S. B.; El-Haddad, G.; Fidelman, N.; Yarmohammadi, H.; Sze, D.; Salem, R.; Metz, D.; Soulen, M. C.
Pancreas (2016)

Fulltext@MSK | Save

Multicenter prospective phase II trial of bevacizumab (bev) for progressive pancreatic neuroendocrine tumor (PNET)

Meeting Abstract

Hobday, T.; Yin, J.; Pettinger, A.; Strosberg, J.; Reidy-Lagunes, D.; Chen, H.; Erlichman, C.
Pancreas (2016)

Fulltext@MSK | Save

Design of a phase 2, prospective, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of lanreotide depot 120 mg in patients with well differentiated, advanced lung, or thymus neuroendocrine tumors (NETs)

Meeting Abstract

Reidy-Lagunes, D.; Wolin, E. M.; Pitman-Lowenthal, S.; Cox, D.; Kulke, M. H.
Pancreas (2016)

Fulltext@MSK | Save

A vector with a single promoter for in vitro transcription and mammalian cell expression of CRISPR gRNAs

Meeting Abstract

Romanienko, P. J.; Giacalone, J.; Ingenito, J.; Wang, Y. J.; Isaka, M.; Johnson, T.; You, Y.; Mark, W. H.
Transgenic Research (2016)

Fulltext@MSK | Save

Is next-generation sequencing (NGS) ready for routine clinical practice in advanced well differentiated pancreatic neuroendocrine tumors (WD panNETs): Results of a prospective study utilizing MSK-IMPACT (Memorial Sloan Kettering Integrated Mutation Profiling of Actionable Cancer Targets)

Meeting Abstract

Raj, N.; Soumerai, T.; Valentino, E.; Reidy-Lagunes, D.
Pancreas (2016)

Fulltext@MSK | Save

Identification of SETD2 genetic alterations in patients with advanced well differentiated pancreatic neuroendocrine tumors (WD panNETs)

Meeting Abstract

Raj, N.; Soumerai, T.; Valentino, E.; Reidy-Lagunes, D.
Pancreas (2016)

Fulltext@MSK | Save